Loading clinical trials...
Loading clinical trials...
The Impact of Humeral Component Version on Outcomes Following Reverse Total Shoulder Arthroplasty: A Prospective Randomized Controlled Trial
Conditions
Interventions
0 degrees humeral component version
30 degrees humeral component retroversion
Locations
1
United States
Beaumont Health
Royal Oak, Michigan, United States
Start Date
May 12, 2017
Primary Completion Date
May 23, 2023
Completion Date
May 23, 2023
Last Updated
March 5, 2024
NCT06505135
NCT03547947
NCT07464977
NCT01405781
NCT02588027
NCT01778777
Lead Sponsor
Corewell Health East
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions